H. Wedemeyer Et Al. , "72 week data of the HIDIT-1 trial: A multicenter randomised study comparing peginterferon alpha-2a plus adefovir vs. peginterferon alpha-2a plus placebo vs. adefovir in chronic delta hepatitis," 42th Annual Meeting of the European-Association-for-the-Study-of-the-Liver , vol.46, Barcelona, Spain, 2007
Wedemeyer, H. Et Al. 2007. 72 week data of the HIDIT-1 trial: A multicenter randomised study comparing peginterferon alpha-2a plus adefovir vs. peginterferon alpha-2a plus placebo vs. adefovir in chronic delta hepatitis. 42th Annual Meeting of the European-Association-for-the-Study-of-the-Liver , (Barcelona, Spain).
Wedemeyer, H., Yurdaydin, C., Dalekos, G., Erhardt, A., Cakaloglu, Y., Degertekin, H., ... Gurel, S.(2007). 72 week data of the HIDIT-1 trial: A multicenter randomised study comparing peginterferon alpha-2a plus adefovir vs. peginterferon alpha-2a plus placebo vs. adefovir in chronic delta hepatitis . 42th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Barcelona, Spain
Wedemeyer, H. Et Al. "72 week data of the HIDIT-1 trial: A multicenter randomised study comparing peginterferon alpha-2a plus adefovir vs. peginterferon alpha-2a plus placebo vs. adefovir in chronic delta hepatitis," 42th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Barcelona, Spain, 2007
Wedemeyer, H. Et Al. "72 week data of the HIDIT-1 trial: A multicenter randomised study comparing peginterferon alpha-2a plus adefovir vs. peginterferon alpha-2a plus placebo vs. adefovir in chronic delta hepatitis." 42th Annual Meeting of the European-Association-for-the-Study-of-the-Liver , Barcelona, Spain, 2007
Wedemeyer, H. Et Al. (2007) . "72 week data of the HIDIT-1 trial: A multicenter randomised study comparing peginterferon alpha-2a plus adefovir vs. peginterferon alpha-2a plus placebo vs. adefovir in chronic delta hepatitis." 42th Annual Meeting of the European-Association-for-the-Study-of-the-Liver , Barcelona, Spain.
@conferencepaper{conferencepaper, author={H. Wedemeyer Et Al. }, title={72 week data of the HIDIT-1 trial: A multicenter randomised study comparing peginterferon alpha-2a plus adefovir vs. peginterferon alpha-2a plus placebo vs. adefovir in chronic delta hepatitis}, congress name={42th Annual Meeting of the European-Association-for-the-Study-of-the-Liver}, city={Barcelona}, country={Spain}, year={2007}}